FTC Intervenes in Teva Pharmaceutical Industries' Proposed $8.9 Billion Acquisition of Barr Pharmaceuticals
Date
Teva Pharmaceuticals Industries Ltd.’s has settled Federal Trade Commission charges that its proposed $8.9 billion acquisition of rival generic drugmaker Barr Pharmaceuticals Inc. would be...